CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2023	$ 379,913		$ 503,354	$ (123,770)	$ 329
Beginning balance (in shares) at Dec. 31, 2023		48,338,769
MEMBERS' DEFICIT
Common stock issued, net of issuance costs	449,955	$ 1	449,954
Common stock issued, net of issuance costs (in shares)		7,790,321
Vesting of restricted common stock (in shares)		237,665
Issuance of common stock upon exercise of stock options	24		24
Issuance of common stock upon exercise of stock options (in shares)		1,047
Equity-based compensation expense	4,186		4,186
Unrealized gain (loss) on marketable securities, net of tax	(506)				(506)
Net loss	(32,094)			(32,094)
Ending balance at Mar. 31, 2024	801,478	$ 1	957,518	(155,864)	(177)
Ending balance (in shares) at Mar. 31, 2024		56,367,802
Beginning balance at Dec. 31, 2024	716,794	$ 1	1,021,794	(305,916)	915
Beginning balance (in shares) at Dec. 31, 2024		58,062,898
MEMBERS' DEFICIT
Vesting of restricted common stock (in shares)		213,104
Issuance of common stock upon exercise of stock options	$ 622		622
Issuance of common stock upon exercise of stock options (in shares)	28,799	28,799
Equity-based compensation expense	$ 11,126		11,126
Unrealized gain (loss) on marketable securities, net of tax	159				159
Net loss	(55,339)			(55,339)
Ending balance at Mar. 31, 2025	$ 673,362	$ 1	$ 1,033,542	$ (361,255)	$ 1,074
Ending balance (in shares) at Mar. 31, 2025		58,304,801